21-CHLORO-9-FLUORO-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3,20-DIOXOPREGNA-1,4-DIEN-17-YL PROPANOATE
UNII KOG6AE3Q8J
Substance Identification & Data
This profile provides standardized clinical and technical data for 21-chloro-9-fluoro-11.beta.-hydroxy-16.alpha.-methyl-3,20-dioxopregna-1,4-dien-17-yl Propanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KOG6AE3Q8J.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 25122-52-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H32ClFO5 CBGUOGMQLZIXBE-OCUNRLNVSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 21-chloro-9-fluoro-11.beta.-hydroxy-16.alpha.-methyl-3,20-dioxopregna-1,4-dien-17-yl Propanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.